Sfoglia per Relatore
Mostrati risultati da 1 a 12 di 12
Aptamers and Triple Negative Breast Cancer: applications and perspectives in therapy
2023/2024 PEPI, GREGORIO
Breast cancer and tumor microenvironment: the influence of cancer-associated fibroblasts on drug resistance and treatment efficacy
2022/2023 RAYMONDI, CHIARA
Cellular Senescence and Cancer: the use of pro-senescence and senolytic therapy to kill cancer cells
2022/2023 DE CARLO, LUCA
Dissecting the Stroma-Tumor cross talk in Breast Cancer: the impact of Cancer Associated Fibroblasts on Drug Resistance
2022/2023 LOBASCIO, ANDREA
E2F1, more than just a cell-cycle controller. Metabolic reprogramming, EMT, metastasization and opportunities for treatment mediated by E2F1 and its coregulators in Cancer.
2019/2020 GRIFFA, ALBERTO
Gene co-expression networks in Basal-Like Breast Cancer allowed to identify E2F3 and TFDP1 transcription factors as central hubs regulating aggressiveness features
2021/2022 CUGUSI, MICHELE
Il ruolo della lisina metiltransferasi 2A (KMT2A) nella leucemia linfoblastica acuta infantile
2021/2022 BATTISTELLA, ALESSIO
Mastering Immune Activation: Precision Targeting of ER Stress and STAT3 in Cancer Therapy
2023/2024 MARCHETTI, ANDREA ROBERTO
STAT3 target genes encoding for secreted proteins mediate the cross-talk between cancer-associated fibroblasts and breast cancer cells
2019/2020 AVERSANO STABILE, SIMONA
STAT3, IP3R3 and mTOR interplay in the regulation of calcium homeostasis and apoptosis in breast cancer
2019/2020 VIAVATTENE, DANIELE
Targeted Non-invasive prenatal testing of T21, T18, and T13: performance assessment and feasibility of implementation in Piedmont NHS
2019/2020 BONDIELLI, GIULIA
The Crosstalk between Prostate Cancer and the Tumor Microenvironment: A Focus on Cancer-Associated Fibroblasts (CAFs) and STAT3
2023/2024 ESMAILI, MAHSHID
Mostrati risultati da 1 a 12 di 12
Legenda icone
- file disponibili solo agli amministratori
- nessun file disponibile